معرفی
Dr. Mark Neilly is a Clinical Research Fellow at the School of Cancer Sciences, University of Glasgow. His research focuses on thoracic oncology and pulmonology, particularly the progression of benign pleural inflammation to mesothelioma and diagnostic methods for pleural diseases.
Key research themes include:
- Mesothelioma pathogenesis
- Lung cancer staging techniques
- Systematic reviews in thoracic oncology
- Pleural effusion analysis
Publications trend: Recent works emphasize cancer progression mechanisms, diagnostic imaging, and clinical protocols. Notably, his 2024 meta-analysis explores mesothelioma evolution from benign conditions, while the 2023 STRATIFY protocol introduces thoracoscopic staging for lung cancer.
Technical teams: Active member of the Mesothelioma Research Group at Glasgow University.
۰مقاله منتشرشده
